The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Miconazole Market Research Report 2024
Synopsis
An imidazole antifungal agent that is used topically and by intravenous infusion.
The global Miconazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Miconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Miconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Miconazole in Skin Infections is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Miconazole include Johnson & Johnson (Ortho-McNeil Pharmaceutical), Praelia Pharmaceuticals (Vestiq), Endo, Midatech Pharma, Actavis (TEVA ), ConvaTec, Cardinal Health, Monsanto and Polichem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Miconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Miconazole.
Report Scope
The Miconazole market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Miconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Miconazole companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson (Ortho-McNeil Pharmaceutical)
Praelia Pharmaceuticals (Vestiq)
Endo
Midatech Pharma
Actavis (TEVA )
ConvaTec
Cardinal Health
Monsanto
Polichem
Guangxi Kanghua Pharmaceutical
Jiangsu Yuanheng Pharmaceutical
Hubei Dongxin Pharmaceutical
Xi'an Yangsen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Nanchang Baiji Pharmaceutical
Weihai Huaxin Pharmaceutical Group
Beijing Langyi Pharmaceutical
Sinopharm group
Chuankang Pharmaceutical
GMP
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
China Resources Zizhu Pharmaceutical
Guangzhou Langsheng Pharmaceutical
Segment by Type
Suppositories
Tablets
Soft Capsule
Injection
Cream
Lotion
Segment by Application
Skin Infections
Fungal Infection Of Vagina Or Penis
Aspergillus Infection Of The Eye
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Miconazole companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An imidazole antifungal agent that is used topically and by intravenous infusion.
The global Miconazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Miconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Miconazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Miconazole in Skin Infections is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Miconazole include Johnson & Johnson (Ortho-McNeil Pharmaceutical), Praelia Pharmaceuticals (Vestiq), Endo, Midatech Pharma, Actavis (TEVA ), ConvaTec, Cardinal Health, Monsanto and Polichem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Miconazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Miconazole.
Report Scope
The Miconazole market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Miconazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Miconazole companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson (Ortho-McNeil Pharmaceutical)
Praelia Pharmaceuticals (Vestiq)
Endo
Midatech Pharma
Actavis (TEVA )
ConvaTec
Cardinal Health
Monsanto
Polichem
Guangxi Kanghua Pharmaceutical
Jiangsu Yuanheng Pharmaceutical
Hubei Dongxin Pharmaceutical
Xi'an Yangsen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Nanchang Baiji Pharmaceutical
Weihai Huaxin Pharmaceutical Group
Beijing Langyi Pharmaceutical
Sinopharm group
Chuankang Pharmaceutical
GMP
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
China Resources Zizhu Pharmaceutical
Guangzhou Langsheng Pharmaceutical
Segment by Type
Suppositories
Tablets
Soft Capsule
Injection
Cream
Lotion
Segment by Application
Skin Infections
Fungal Infection Of Vagina Or Penis
Aspergillus Infection Of The Eye
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Miconazole companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Miconazole Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Suppositories
1.2.3 Tablets
1.2.4 Soft Capsule
1.2.5 Injection
1.2.6 Cream
1.2.7 Lotion
1.3 Market by Application
1.3.1 Global Miconazole Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Skin Infections
1.3.3 Fungal Infection Of Vagina Or Penis
1.3.4 Aspergillus Infection Of The Eye
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Miconazole Market Perspective (2019-2030)
2.2 Miconazole Growth Trends by Region
2.2.1 Global Miconazole Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Miconazole Historic Market Size by Region (2019-2024)
2.2.3 Miconazole Forecasted Market Size by Region (2025-2030)
2.3 Miconazole Market Dynamics
2.3.1 Miconazole Industry Trends
2.3.2 Miconazole Market Drivers
2.3.3 Miconazole Market Challenges
2.3.4 Miconazole Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Miconazole Players by Revenue
3.1.1 Global Top Miconazole Players by Revenue (2019-2024)
3.1.2 Global Miconazole Revenue Market Share by Players (2019-2024)
3.2 Global Miconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Miconazole Revenue
3.4 Global Miconazole Market Concentration Ratio
3.4.1 Global Miconazole Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Miconazole Revenue in 2023
3.5 Miconazole Key Players Head office and Area Served
3.6 Key Players Miconazole Product Solution and Service
3.7 Date of Enter into Miconazole Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Miconazole Breakdown Data by Type
4.1 Global Miconazole Historic Market Size by Type (2019-2024)
4.2 Global Miconazole Forecasted Market Size by Type (2025-2030)
5 Miconazole Breakdown Data by Application
5.1 Global Miconazole Historic Market Size by Application (2019-2024)
5.2 Global Miconazole Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Miconazole Market Size (2019-2030)
6.2 North America Miconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Miconazole Market Size by Country (2019-2024)
6.4 North America Miconazole Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Miconazole Market Size (2019-2030)
7.2 Europe Miconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Miconazole Market Size by Country (2019-2024)
7.4 Europe Miconazole Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Miconazole Market Size (2019-2030)
8.2 Asia-Pacific Miconazole Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Miconazole Market Size by Region (2019-2024)
8.4 Asia-Pacific Miconazole Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Miconazole Market Size (2019-2030)
9.2 Latin America Miconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Miconazole Market Size by Country (2019-2024)
9.4 Latin America Miconazole Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Miconazole Market Size (2019-2030)
10.2 Middle East & Africa Miconazole Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Miconazole Market Size by Country (2019-2024)
10.4 Middle East & Africa Miconazole Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson (Ortho-McNeil Pharmaceutical)
11.1.1 Johnson & Johnson (Ortho-McNeil Pharmaceutical) Company Detail
11.1.2 Johnson & Johnson (Ortho-McNeil Pharmaceutical) Business Overview
11.1.3 Johnson & Johnson (Ortho-McNeil Pharmaceutical) Miconazole Introduction
11.1.4 Johnson & Johnson (Ortho-McNeil Pharmaceutical) Revenue in Miconazole Business (2019-2024)
11.1.5 Johnson & Johnson (Ortho-McNeil Pharmaceutical) Recent Development
11.2 Praelia Pharmaceuticals (Vestiq)
11.2.1 Praelia Pharmaceuticals (Vestiq) Company Detail
11.2.2 Praelia Pharmaceuticals (Vestiq) Business Overview
11.2.3 Praelia Pharmaceuticals (Vestiq) Miconazole Introduction
11.2.4 Praelia Pharmaceuticals (Vestiq) Revenue in Miconazole Business (2019-2024)
11.2.5 Praelia Pharmaceuticals (Vestiq) Recent Development
11.3 Endo
11.3.1 Endo Company Detail
11.3.2 Endo Business Overview
11.3.3 Endo Miconazole Introduction
11.3.4 Endo Revenue in Miconazole Business (2019-2024)
11.3.5 Endo Recent Development
11.4 Midatech Pharma
11.4.1 Midatech Pharma Company Detail
11.4.2 Midatech Pharma Business Overview
11.4.3 Midatech Pharma Miconazole Introduction
11.4.4 Midatech Pharma Revenue in Miconazole Business (2019-2024)
11.4.5 Midatech Pharma Recent Development
11.5 Actavis (TEVA )
11.5.1 Actavis (TEVA ) Company Detail
11.5.2 Actavis (TEVA ) Business Overview
11.5.3 Actavis (TEVA ) Miconazole Introduction
11.5.4 Actavis (TEVA ) Revenue in Miconazole Business (2019-2024)
11.5.5 Actavis (TEVA ) Recent Development
11.6 ConvaTec
11.6.1 ConvaTec Company Detail
11.6.2 ConvaTec Business Overview
11.6.3 ConvaTec Miconazole Introduction
11.6.4 ConvaTec Revenue in Miconazole Business (2019-2024)
11.6.5 ConvaTec Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Detail
11.7.2 Cardinal Health Business Overview
11.7.3 Cardinal Health Miconazole Introduction
11.7.4 Cardinal Health Revenue in Miconazole Business (2019-2024)
11.7.5 Cardinal Health Recent Development
11.8 Monsanto
11.8.1 Monsanto Company Detail
11.8.2 Monsanto Business Overview
11.8.3 Monsanto Miconazole Introduction
11.8.4 Monsanto Revenue in Miconazole Business (2019-2024)
11.8.5 Monsanto Recent Development
11.9 Polichem
11.9.1 Polichem Company Detail
11.9.2 Polichem Business Overview
11.9.3 Polichem Miconazole Introduction
11.9.4 Polichem Revenue in Miconazole Business (2019-2024)
11.9.5 Polichem Recent Development
11.10 Guangxi Kanghua Pharmaceutical
11.10.1 Guangxi Kanghua Pharmaceutical Company Detail
11.10.2 Guangxi Kanghua Pharmaceutical Business Overview
11.10.3 Guangxi Kanghua Pharmaceutical Miconazole Introduction
11.10.4 Guangxi Kanghua Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.10.5 Guangxi Kanghua Pharmaceutical Recent Development
11.11 Jiangsu Yuanheng Pharmaceutical
11.11.1 Jiangsu Yuanheng Pharmaceutical Company Detail
11.11.2 Jiangsu Yuanheng Pharmaceutical Business Overview
11.11.3 Jiangsu Yuanheng Pharmaceutical Miconazole Introduction
11.11.4 Jiangsu Yuanheng Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.11.5 Jiangsu Yuanheng Pharmaceutical Recent Development
11.12 Hubei Dongxin Pharmaceutical
11.12.1 Hubei Dongxin Pharmaceutical Company Detail
11.12.2 Hubei Dongxin Pharmaceutical Business Overview
11.12.3 Hubei Dongxin Pharmaceutical Miconazole Introduction
11.12.4 Hubei Dongxin Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.12.5 Hubei Dongxin Pharmaceutical Recent Development
11.13 Xi'an Yangsen Pharmaceutical
11.13.1 Xi'an Yangsen Pharmaceutical Company Detail
11.13.2 Xi'an Yangsen Pharmaceutical Business Overview
11.13.3 Xi'an Yangsen Pharmaceutical Miconazole Introduction
11.13.4 Xi'an Yangsen Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.13.5 Xi'an Yangsen Pharmaceutical Recent Development
11.14 Shandong Luoxin Pharmaceutical Group
11.14.1 Shandong Luoxin Pharmaceutical Group Company Detail
11.14.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.14.3 Shandong Luoxin Pharmaceutical Group Miconazole Introduction
11.14.4 Shandong Luoxin Pharmaceutical Group Revenue in Miconazole Business (2019-2024)
11.14.5 Shandong Luoxin Pharmaceutical Group Recent Development
11.15 Nanchang Baiji Pharmaceutical
11.15.1 Nanchang Baiji Pharmaceutical Company Detail
11.15.2 Nanchang Baiji Pharmaceutical Business Overview
11.15.3 Nanchang Baiji Pharmaceutical Miconazole Introduction
11.15.4 Nanchang Baiji Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.15.5 Nanchang Baiji Pharmaceutical Recent Development
11.16 Weihai Huaxin Pharmaceutical Group
11.16.1 Weihai Huaxin Pharmaceutical Group Company Detail
11.16.2 Weihai Huaxin Pharmaceutical Group Business Overview
11.16.3 Weihai Huaxin Pharmaceutical Group Miconazole Introduction
11.16.4 Weihai Huaxin Pharmaceutical Group Revenue in Miconazole Business (2019-2024)
11.16.5 Weihai Huaxin Pharmaceutical Group Recent Development
11.17 Beijing Langyi Pharmaceutical
11.17.1 Beijing Langyi Pharmaceutical Company Detail
11.17.2 Beijing Langyi Pharmaceutical Business Overview
11.17.3 Beijing Langyi Pharmaceutical Miconazole Introduction
11.17.4 Beijing Langyi Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.17.5 Beijing Langyi Pharmaceutical Recent Development
11.18 Sinopharm group
11.18.1 Sinopharm group Company Detail
11.18.2 Sinopharm group Business Overview
11.18.3 Sinopharm group Miconazole Introduction
11.18.4 Sinopharm group Revenue in Miconazole Business (2019-2024)
11.18.5 Sinopharm group Recent Development
11.19 Chuankang Pharmaceutical
11.19.1 Chuankang Pharmaceutical Company Detail
11.19.2 Chuankang Pharmaceutical Business Overview
11.19.3 Chuankang Pharmaceutical Miconazole Introduction
11.19.4 Chuankang Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.19.5 Chuankang Pharmaceutical Recent Development
11.20 GMP
11.20.1 GMP Company Detail
11.20.2 GMP Business Overview
11.20.3 GMP Miconazole Introduction
11.20.4 GMP Revenue in Miconazole Business (2019-2024)
11.20.5 GMP Recent Development
11.21 Hubei Gedian Renfu Pharmaceutical
11.21.1 Hubei Gedian Renfu Pharmaceutical Company Detail
11.21.2 Hubei Gedian Renfu Pharmaceutical Business Overview
11.21.3 Hubei Gedian Renfu Pharmaceutical Miconazole Introduction
11.21.4 Hubei Gedian Renfu Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.21.5 Hubei Gedian Renfu Pharmaceutical Recent Development
11.22 Shanghai Xinhualian Pharmaceutical
11.22.1 Shanghai Xinhualian Pharmaceutical Company Detail
11.22.2 Shanghai Xinhualian Pharmaceutical Business Overview
11.22.3 Shanghai Xinhualian Pharmaceutical Miconazole Introduction
11.22.4 Shanghai Xinhualian Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.22.5 Shanghai Xinhualian Pharmaceutical Recent Development
11.23 China Resources Zizhu Pharmaceutical
11.23.1 China Resources Zizhu Pharmaceutical Company Detail
11.23.2 China Resources Zizhu Pharmaceutical Business Overview
11.23.3 China Resources Zizhu Pharmaceutical Miconazole Introduction
11.23.4 China Resources Zizhu Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.23.5 China Resources Zizhu Pharmaceutical Recent Development
11.24 Guangzhou Langsheng Pharmaceutical
11.24.1 Guangzhou Langsheng Pharmaceutical Company Detail
11.24.2 Guangzhou Langsheng Pharmaceutical Business Overview
11.24.3 Guangzhou Langsheng Pharmaceutical Miconazole Introduction
11.24.4 Guangzhou Langsheng Pharmaceutical Revenue in Miconazole Business (2019-2024)
11.24.5 Guangzhou Langsheng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Miconazole Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Suppositories
Table 3. Key Players of Tablets
Table 4. Key Players of Soft Capsule
Table 5. Key Players of Injection
Table 6. Key Players of Cream
Table 7. Key Players of Lotion
Table 8. Global Miconazole Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Miconazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Miconazole Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Miconazole Market Share by Region (2019-2024)
Table 12. Global Miconazole Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Miconazole Market Share by Region (2025-2030)
Table 14. Miconazole Market Trends
Table 15. Miconazole Market Drivers
Table 16. Miconazole Market Challenges
Table 17. Miconazole Market Restraints
Table 18. Global Miconazole Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Miconazole Market Share by Players (2019-2024)
Table 20. Global Top Miconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Miconazole as of 2023)
Table 21. Ranking of Global Top Miconazole Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Miconazole Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Miconazole Product Solution and Service
Table 25. Date of Enter into Miconazole Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Miconazole Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Miconazole Revenue Market Share by Type (2019-2024)
Table 29. Global Miconazole Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Miconazole Revenue Market Share by Type (2025-2030)
Table 31. Global Miconazole Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Miconazole Revenue Market Share by Application (2019-2024)
Table 33. Global Miconazole Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Miconazole Revenue Market Share by Application (2025-2030)
Table 35. North America Miconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Miconazole Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Miconazole Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Miconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Miconazole Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Miconazole Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Miconazole Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Miconazole Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Miconazole Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Miconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Miconazole Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Miconazole Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Miconazole Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Miconazole Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Miconazole Market Size by Country (2025-2030) & (US$ Million)
Table 50. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Company Detail
Table 51. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Business Overview
Table 52. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Miconazole Product
Table 53. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 54. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Recent Development
Table 55. Praelia Pharmaceuticals (Vestiq) Company Detail
Table 56. Praelia Pharmaceuticals (Vestiq) Business Overview
Table 57. Praelia Pharmaceuticals (Vestiq) Miconazole Product
Table 58. Praelia Pharmaceuticals (Vestiq) Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 59. Praelia Pharmaceuticals (Vestiq) Recent Development
Table 60. Endo Company Detail
Table 61. Endo Business Overview
Table 62. Endo Miconazole Product
Table 63. Endo Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 64. Endo Recent Development
Table 65. Midatech Pharma Company Detail
Table 66. Midatech Pharma Business Overview
Table 67. Midatech Pharma Miconazole Product
Table 68. Midatech Pharma Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 69. Midatech Pharma Recent Development
Table 70. Actavis (TEVA ) Company Detail
Table 71. Actavis (TEVA ) Business Overview
Table 72. Actavis (TEVA ) Miconazole Product
Table 73. Actavis (TEVA ) Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 74. Actavis (TEVA ) Recent Development
Table 75. ConvaTec Company Detail
Table 76. ConvaTec Business Overview
Table 77. ConvaTec Miconazole Product
Table 78. ConvaTec Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 79. ConvaTec Recent Development
Table 80. Cardinal Health Company Detail
Table 81. Cardinal Health Business Overview
Table 82. Cardinal Health Miconazole Product
Table 83. Cardinal Health Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 84. Cardinal Health Recent Development
Table 85. Monsanto Company Detail
Table 86. Monsanto Business Overview
Table 87. Monsanto Miconazole Product
Table 88. Monsanto Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 89. Monsanto Recent Development
Table 90. Polichem Company Detail
Table 91. Polichem Business Overview
Table 92. Polichem Miconazole Product
Table 93. Polichem Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 94. Polichem Recent Development
Table 95. Guangxi Kanghua Pharmaceutical Company Detail
Table 96. Guangxi Kanghua Pharmaceutical Business Overview
Table 97. Guangxi Kanghua Pharmaceutical Miconazole Product
Table 98. Guangxi Kanghua Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 99. Guangxi Kanghua Pharmaceutical Recent Development
Table 100. Jiangsu Yuanheng Pharmaceutical Company Detail
Table 101. Jiangsu Yuanheng Pharmaceutical Business Overview
Table 102. Jiangsu Yuanheng Pharmaceutical Miconazole Product
Table 103. Jiangsu Yuanheng Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 104. Jiangsu Yuanheng Pharmaceutical Recent Development
Table 105. Hubei Dongxin Pharmaceutical Company Detail
Table 106. Hubei Dongxin Pharmaceutical Business Overview
Table 107. Hubei Dongxin Pharmaceutical Miconazole Product
Table 108. Hubei Dongxin Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 109. Hubei Dongxin Pharmaceutical Recent Development
Table 110. Xi'an Yangsen Pharmaceutical Company Detail
Table 111. Xi'an Yangsen Pharmaceutical Business Overview
Table 112. Xi'an Yangsen Pharmaceutical Miconazole Product
Table 113. Xi'an Yangsen Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 114. Xi'an Yangsen Pharmaceutical Recent Development
Table 115. Shandong Luoxin Pharmaceutical Group Company Detail
Table 116. Shandong Luoxin Pharmaceutical Group Business Overview
Table 117. Shandong Luoxin Pharmaceutical Group Miconazole Product
Table 118. Shandong Luoxin Pharmaceutical Group Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 119. Shandong Luoxin Pharmaceutical Group Recent Development
Table 120. Nanchang Baiji Pharmaceutical Company Detail
Table 121. Nanchang Baiji Pharmaceutical Business Overview
Table 122. Nanchang Baiji Pharmaceutical Miconazole Product
Table 123. Nanchang Baiji Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 124. Nanchang Baiji Pharmaceutical Recent Development
Table 125. Weihai Huaxin Pharmaceutical Group Company Detail
Table 126. Weihai Huaxin Pharmaceutical Group Business Overview
Table 127. Weihai Huaxin Pharmaceutical Group Miconazole Product
Table 128. Weihai Huaxin Pharmaceutical Group Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 129. Weihai Huaxin Pharmaceutical Group Recent Development
Table 130. Beijing Langyi Pharmaceutical Company Detail
Table 131. Beijing Langyi Pharmaceutical Business Overview
Table 132. Beijing Langyi Pharmaceutical Miconazole Product
Table 133. Beijing Langyi Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 134. Beijing Langyi Pharmaceutical Recent Development
Table 135. Sinopharm group Company Detail
Table 136. Sinopharm group Business Overview
Table 137. Sinopharm group Miconazole Product
Table 138. Sinopharm group Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 139. Sinopharm group Recent Development
Table 140. Chuankang Pharmaceutical Company Detail
Table 141. Chuankang Pharmaceutical Business Overview
Table 142. Chuankang Pharmaceutical Miconazole Product
Table 143. Chuankang Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 144. Chuankang Pharmaceutical Recent Development
Table 145. GMP Company Detail
Table 146. GMP Business Overview
Table 147. GMP Miconazole Product
Table 148. GMP Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 149. GMP Recent Development
Table 150. Hubei Gedian Renfu Pharmaceutical Company Detail
Table 151. Hubei Gedian Renfu Pharmaceutical Business Overview
Table 152. Hubei Gedian Renfu Pharmaceutical Miconazole Product
Table 153. Hubei Gedian Renfu Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 154. Hubei Gedian Renfu Pharmaceutical Recent Development
Table 155. Shanghai Xinhualian Pharmaceutical Company Detail
Table 156. Shanghai Xinhualian Pharmaceutical Business Overview
Table 157. Shanghai Xinhualian Pharmaceutical Miconazole Product
Table 158. Shanghai Xinhualian Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 159. Shanghai Xinhualian Pharmaceutical Recent Development
Table 160. China Resources Zizhu Pharmaceutical Company Detail
Table 161. China Resources Zizhu Pharmaceutical Business Overview
Table 162. China Resources Zizhu Pharmaceutical Miconazole Product
Table 163. China Resources Zizhu Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 164. China Resources Zizhu Pharmaceutical Recent Development
Table 165. Guangzhou Langsheng Pharmaceutical Company Detail
Table 166. Guangzhou Langsheng Pharmaceutical Business Overview
Table 167. Guangzhou Langsheng Pharmaceutical Miconazole Product
Table 168. Guangzhou Langsheng Pharmaceutical Revenue in Miconazole Business (2019-2024) & (US$ Million)
Table 169. Guangzhou Langsheng Pharmaceutical Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Miconazole Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Miconazole Market Share by Type: 2023 VS 2030
Figure 3. Suppositories Features
Figure 4. Tablets Features
Figure 5. Soft Capsule Features
Figure 6. Injection Features
Figure 7. Cream Features
Figure 8. Lotion Features
Figure 9. Global Miconazole Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Miconazole Market Share by Application: 2023 VS 2030
Figure 11. Skin Infections Case Studies
Figure 12. Fungal Infection Of Vagina Or Penis Case Studies
Figure 13. Aspergillus Infection Of The Eye Case Studies
Figure 14. Other Case Studies
Figure 15. Miconazole Report Years Considered
Figure 16. Global Miconazole Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Miconazole Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Miconazole Market Share by Region: 2023 VS 2030
Figure 19. Global Miconazole Market Share by Players in 2023
Figure 20. Global Top Miconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Miconazole as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Miconazole Revenue in 2023
Figure 22. North America Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Miconazole Market Share by Country (2019-2030)
Figure 24. United States Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Miconazole Market Share by Country (2019-2030)
Figure 28. Germany Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Miconazole Market Share by Region (2019-2030)
Figure 36. China Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Miconazole Market Share by Country (2019-2030)
Figure 44. Mexico Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Miconazole Market Share by Country (2019-2030)
Figure 48. Turkey Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Miconazole Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Johnson & Johnson (Ortho-McNeil Pharmaceutical) Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 51. Praelia Pharmaceuticals (Vestiq) Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 52. Endo Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 53. Midatech Pharma Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 54. Actavis (TEVA ) Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 55. ConvaTec Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 56. Cardinal Health Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 57. Monsanto Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 58. Polichem Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 59. Guangxi Kanghua Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 60. Jiangsu Yuanheng Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 61. Hubei Dongxin Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 62. Xi'an Yangsen Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 63. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 64. Nanchang Baiji Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 65. Weihai Huaxin Pharmaceutical Group Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 66. Beijing Langyi Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 67. Sinopharm group Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 68. Chuankang Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 69. GMP Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 70. Hubei Gedian Renfu Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 71. Shanghai Xinhualian Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 72. China Resources Zizhu Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 73. Guangzhou Langsheng Pharmaceutical Revenue Growth Rate in Miconazole Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
